Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment
- 21 September 2018
- journal article
- research article
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 20 (4) , 498-503
Abstract
Increases in plasma of β-amyloids (Aβ) and tau proteins have been noted in patients with Alzheimer’s dementia (AD). Our study investigated the associations of plasma Aβ and tau proteins with dementia in stroke patients. This cross-sectional study recruited 24 controls (mean age: 67.4 ± 7.5 years, 33.3% male), 27 stroke patients without dementia (mean age: 70.7 ± 6.9 years, 60.7% male), 34 stroke patients with dementia (mean age: 78.3 ± 5.3 years, 45.5% male, Clinical Dementia Ranking (CDR): 1.46 ± 0.63), and 21 AD patients (mean age: 77.1 ± 9.1 years, 42.9% male, CDR: 1.43 ± 0.60) from a medical center. Dementia was defined as a CDR scale score of ≥ 1. The plasma levels of Aβ-40, Aβ-42, and tau were analyzed using immunomagnetic reduction. One-way analysis of variance was used to compare the differences in measured protein levels between the groups. The results indicated that plasma levels of tau and Aβ-42, but not Aβ-40, in stroke patients were significantly higher than in the controls. After adjustment for age, sex, diabetes mellitus, hypertension, and hyperlipidemia, only plasma level of Aβ-42 remained significantly higher in stroke patients with dementia than in those without dementia (OR 1.85, 1.25–2.75, p = 0.002). In summary, our results suggest that plasma Aβ-42 is a potential biomarker for dementia in stroke patients.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (105-2314-B-002 -001)
This publication has 16 references indexed in Scilit:
- Amyloid Burden, Neuroinflammation, and Links to Cognitive Decline After Ischemic StrokeStroke, 2014
- Complexity of heart rate variability predicts outcome in intensive care unit admitted patients with acute strokeJournal of Neurology, Neurosurgery & Psychiatry, 2014
- The Pathobiology of Vascular DementiaNeuron, 2013
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s DiseaseACS Chemical Neuroscience, 2013
- Functional Role of Soluble Receptor for Advanced Glycation End Products in StrokeArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Amyloid deposition after cerebral hypoperfusion: Evidenced on [18F]AV-45 positron emission tomographyJournal of the Neurological Sciences, 2012
- Clearance of Amyloid-β Protein Deposits in Transgenic Mice following Focal Cerebral IschemiaNeurodegenerative Diseases, 2012
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Vascular dementiaNeurology, 1993
- Dementia diagnosisNeurology, 1989